BRII-835 (VIR-2218)

BRII-835 · Brii Biosciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRII-835 (VIR-2218), covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients [Phase 2]

See pricing